SAB Biotherapeutics (SABS) Notes Payables (2020 - 2025)
SAB Biotherapeutics (SABS) reported Notes Payables of $138554.0 for Q1 2025, down 83.42% on a YoY basis from $835467.0 in Q1 2024, and down 49.77% quarter-over-quarter from $275849.0 in Q4 2024.
SAB Biotherapeutics (SABS) Notes Payables (2020 - 2025) Analysis & Trends
SAB Biotherapeutics has reported Notes Payables for 6 years, with the latest figure at $138554.0 in Q1 2025.
- For the quarter ending Q1 2025, Notes Payables fell 83.42% year-over-year to $138554.0; the trailing twelve-month figure through Mar 2025 stood at $138554.0 (down 83.42% YoY), and the FY2024 full-year result was $275849.0, down 73.75% from the prior year.
- Notes Payables for Q1 2025 stood at $138554.0, down from $275849.0 in the prior quarter.
- The five-year high for Notes Payables was $1.8 million in Q4 2021, with the low at $25013.0 in Q3 2022.
- Historically, Notes Payables has averaged $609781.8 across 5 years, with a median of $541644.0 in 2023.
- Annual changes were most pronounced in 2023 — Notes Payables surged 2065.45% — and 2025, when it slumped 83.42%.
- SAB Biotherapeutics' Notes Payables stood at $1.8 million in 2021, then plunged by 57.0% to $772665.0 in 2022, then jumped by 36.0% to $1.1 million in 2023, then plunged by 73.75% to $275849.0 in 2024, then sank by 49.77% to $138554.0 in 2025.
- The last three Notes Payables figures came in at $138554.0 (Q1 2025), $275849.0 (Q4 2024), and $615818.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | SAB Biotherapeutics | 214.77 Mn | 214.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 138,554.00 |
| Dec 31, 2024 | 275,849.00 |
| Jun 30, 2024 | 615,818.00 |
| Mar 31, 2024 | 835,467.00 |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 541,644.00 |
| Jun 30, 2023 | 111,894.00 |
| Mar 31, 2023 | 444,478.00 |
| Dec 31, 2022 | 772,665.00 |
| Sep 30, 2022 | 25,013.00 |
| Jun 30, 2022 | 278,441.00 |
| Mar 31, 2022 | 1.04 Mn |
| Dec 31, 2021 | 1.80 Mn |
| Dec 31, 2020 | 538,731.00 |